Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. T...

Full description

Saved in:
Bibliographic Details
Published inDiabetes, metabolic syndrome and obesity Vol. 12; pp. 2405 - 2410
Main Authors Tripolino, Cesare, Irace, Concetta, Cutruzzolà, Antonio, Parise, Martina, Barone, Milena, Scicchitano, Caterina, Cortese, Claudio, Gnasso, Agostino
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.11.2019
Taylor & Francis Ltd
Dove
Dove Medical Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
AbstractList Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and microvascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice. Keywords: fatty liver, type 1 diabetes, diabetes complications
Cesare Tripolino,1 Concetta Irace,2 Antonio Cutruzzolà,2 Martina Parise,1 Milena Barone,1 Caterina Scicchitano,1 Claudio Cortese,3 Agostino Gnasso1 1Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy; 2Department of Health Science, University Magna Graecia, Catanzaro, Italy; 3Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, ItalyCorrespondence: Agostino GnassoMetabolic Diseases Unit, Department of Clinical and Experimental Medicine, Mater Domini Hospital, Magna Græcia University, Catanzaro, ItalyTel +39 9613697039Fax +39 9613697250Email gnasso@unicz.itIntroduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance.Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM.Methods: Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level.Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications.Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.Keywords: fatty liver, type 1 diabetes, diabetes complications
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
INTRODUCTIONNon-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. AIMThe aim of the present study was to evaluate the possible association between HSI and complications in T1DM. METHODSMedical records of patients with T1DM were evaluated. Macro- and micro-vascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. RESULTSOf the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. CONCLUSIONThese findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
Audience Academic
Author Cutruzzolà, Antonio
Gnasso, Agostino
Cortese, Claudio
Irace, Concetta
Tripolino, Cesare
Parise, Martina
Scicchitano, Caterina
Barone, Milena
Author_xml – sequence: 1
  givenname: Cesare
  surname: Tripolino
  fullname: Tripolino, Cesare
  organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy
– sequence: 2
  givenname: Concetta
  orcidid: 0000-0001-5182-5473
  surname: Irace
  fullname: Irace, Concetta
  organization: Department of Health Science, University Magna Graecia, Catanzaro, Italy
– sequence: 3
  givenname: Antonio
  surname: Cutruzzolà
  fullname: Cutruzzolà, Antonio
  organization: Department of Health Science, University Magna Graecia, Catanzaro, Italy
– sequence: 4
  givenname: Martina
  surname: Parise
  fullname: Parise, Martina
  organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy
– sequence: 5
  givenname: Milena
  surname: Barone
  fullname: Barone, Milena
  organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy
– sequence: 6
  givenname: Caterina
  surname: Scicchitano
  fullname: Scicchitano, Caterina
  organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy
– sequence: 7
  givenname: Claudio
  orcidid: 0000-0002-9429-5000
  surname: Cortese
  fullname: Cortese, Claudio
  organization: Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy
– sequence: 8
  givenname: Agostino
  orcidid: 0000-0002-9220-9754
  surname: Gnasso
  fullname: Gnasso, Agostino
  organization: Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31819566$$D View this record in MEDLINE/PubMed
BookMark eNptkk1vEzEQhleoiJbSG2e0EhLiQILH689LpSgFEqmoh5Sz5fXOJo4267DeAP33eJtQEoR9sDV-5rVn_L7MztrQYpa9BjKmwOTHm6-Lu_GCUtBCP8suAKQaSULk2dH-PLuKcU2GIQmj9EV2XoACzYW4yGYz3Nreu3zRo-1D9DGftxX-yucxn8QYnLc9VvlP36_y-4ct5pDfeFtijzGfhs228S6lhza-yp7Xtol4dVgvs2-fP91PZ6Pbuy_z6eR25JgGPaqtIxygZsCptSgo11BQplDWFIVFICVnvBS2EJbowpUasSYgdamghAKKy2y-162CXZtt5ze2ezDBevMYCN3S2C4V1KABTpxTNUENgjGuS6YsE7IQRFS0VDRpXe-1trtyg5XDtu9scyJ6etL6lVmGH0YoyZmSSeD9QaAL33cYe7Px0WHT2BbDLhpa0IJJxenw7rf_oOuw69rUqoGSXDNQ-i-1tKkA39Yh3esGUTMRREmV_pkkavwfKs0KN94lh9Q-xU8S3h0lrNA2_SqGZvf4c6fghz3ouhBjh_VTM4CYwXFmcJw5OC7hb44b-AT_8VfxG3nPzfI
CitedBy_id crossref_primary_10_1177_03946320231223644
crossref_primary_10_3389_fmolb_2022_1019899
crossref_primary_10_1016_j_diabet_2023_101497
crossref_primary_10_3390_jcm10194466
crossref_primary_10_3390_antiox11112260
crossref_primary_10_3390_jpm13071148
crossref_primary_10_1021_acsptsci_3c00218
crossref_primary_10_23736_S2724_6507_20_03290_3
crossref_primary_10_1016_j_hbpd_2023_02_009
crossref_primary_10_1007_s40618_024_02333_2
crossref_primary_10_1155_2022_3150380
crossref_primary_10_1080_13880209_2021_1990969
crossref_primary_10_1136_bmjdrc_2020_001189
crossref_primary_10_1136_bmjopen_2023_073452
ContentType Journal Article
Copyright 2019 Tripolino et al.
COPYRIGHT 2019 Dove Medical Press Limited
2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2019 Tripolino et al. 2019 Tripolino et al.
Copyright_xml – notice: 2019 Tripolino et al.
– notice: COPYRIGHT 2019 Dove Medical Press Limited
– notice: 2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2019 Tripolino et al. 2019 Tripolino et al.
DBID NPM
AAYXX
CITATION
3V.
7RV
7XB
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
KB0
M2O
MBDVC
NAPCQ
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.2147/DMSO.S221969
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Central (purchase pre-March 2016)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
Nursing & Allied Health Database (Alumni Edition)
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Public Health
Research Library Prep
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Research Library (Alumni Edition)
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
Health Research Premium Collection
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

PubMed
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Tripolino et al
EISSN 1178-7007
EndPage 2410
ExternalDocumentID oai_doaj_org_article_150cc8f0e9164459b48a4673606d2b82
A608789690
10_2147_DMSO_S221969
31819566
Genre Journal Article
GeographicLocations Switzerland
GeographicLocations_xml – name: Switzerland
GroupedDBID ---
0YH
29F
2WC
53G
5VS
7RV
8C1
8FI
8FJ
8G5
ABUWG
ACGFO
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKEYQ
BPHCQ
BVXVI
C1A
CCPQU
DIK
DWQXO
E3Z
EBD
EBS
EJD
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
M2O
M48
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TR2
UKHRP
VDV
AAYXX
CITATION
TDBHL
3V.
7XB
8FK
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c4919-fac0511f4152aae625913248e7f2e6ae10b545b6a36a093cb9eef0179b81b1313
IEDL.DBID RPM
ISSN 1178-7007
IngestDate Tue Oct 22 14:38:43 EDT 2024
Tue Sep 17 21:14:34 EDT 2024
Sat Aug 17 00:13:42 EDT 2024
Thu Oct 10 18:19:51 EDT 2024
Thu Feb 22 23:59:19 EST 2024
Wed Oct 25 09:34:00 EDT 2023
Tue Aug 20 22:11:13 EDT 2024
Thu Sep 26 18:39:19 EDT 2024
Sat Sep 28 08:44:06 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords type 1 diabetes
fatty liver
diabetes complications
Language English
License 2019 Tripolino et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4919-fac0511f4152aae625913248e7f2e6ae10b545b6a36a093cb9eef0179b81b1313
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5182-5473
0000-0002-9429-5000
0000-0002-9220-9754
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875487/
PMID 31819566
PQID 2327594189
PQPubID 3933170
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_150cc8f0e9164459b48a4673606d2b82
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6875487
proquest_miscellaneous_2323478521
proquest_journals_2327594189
gale_infotracmisc_A608789690
gale_infotracacademiconefile_A608789690
gale_healthsolutions_A608789690
crossref_primary_10_2147_DMSO_S221969
pubmed_primary_31819566
PublicationCentury 2000
PublicationDate 20191101
PublicationDateYYYYMMDD 2019-11-01
PublicationDate_xml – month: 11
  year: 2019
  text: 20191101
  day: 01
PublicationDecade 2010
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
– name: Macclesfield
PublicationTitle Diabetes, metabolic syndrome and obesity
PublicationTitleAlternate Diabetes Metab Syndr Obes
PublicationYear 2019
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove
– name: Dove Medical Press
SSID ssj0000070422
Score 2.2933881
Snippet Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several...
Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date,...
INTRODUCTIONNon-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date,...
Cesare Tripolino,1 Concetta Irace,2 Antonio Cutruzzolà,2 Martina Parise,1 Milena Barone,1 Caterina Scicchitano,1 Claudio Cortese,3 Agostino Gnasso1 1Metabolic...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2405
SubjectTerms Atherosclerosis
Biochemistry
Body mass index
Carotid arteries
Complications and side effects
Diabetes
diabetes complications
Diabetic retinopathy
Electrocardiography
Fatty liver
Flow velocity
Insulin
Kidney diseases
Laboratories
Liver
Liver diseases
Medical records
Original Research
Regression analysis
Tomography
Triglycerides
Type 1 diabetes
Type 2 diabetes
Ultrasonic imaging
Variables
Veins & arteries
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gL4ptAASOBOIXaju3Yx1KotkgLh1KpN8v2TkQvWUS2_5-ZOLtKxIELx8QTJZ7J2G-S52fG3unos49Z18kYVWtnoXbamdobyBsprYCRTbj-ZldX-uu1uZ5t9UWcsCIPXBx3goAlZ9cJQByjtfFJu6iJjCTsRiVXRl_hZ8VUAb4tiVuVnVVc3eJxYb3Ttjwnn9eX3z9eKkXSMIv5aJTt_3twns1OS-bkbCo6f8DuTxiSn5Znf8juQP-I3V1Pf8kfs9UKiCedOZF1d9vhZuAXJIrILwa-DwdsOH2C5VSHcsknYszAz-YU8yfs6vzLj7NVPe2YUGftpa-7mDHJZEezcoxAtQ1Wm9pB2ymwEaRIiJiSjY2Nwjc5eYCOcjIhepWNbJ6yo37bw3PGO9XkLMF4tQHdGh2bpFWXhepAqKibir3f-y38KsIYAQsK8m8g_4bJvxX7RE492JCc9XgCgxymIId_BblibygkoawNPSRlOLXCtQ7vIir2YbSgtMTI5DitLsDOkMDVwvJ4YYnplJfN-7CHKZ2HgLCzNV5Lh915e2imK4mi1sP2drRpdOsQDlXsWXlLDp3GgZPWZdqKtYv3Z-GVZUt_83MU-7ZYUGJR-eJ_uPElu4d4z5ellMfsaPf7Fl4hptql12P6_AG0_xij
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVkJcEO8GChgJxCk0dhzHPqG2tNoibUGUSr1ZjjOBXpLSbP8_nsQbNkLiGk-UeMbzsj_PALyTznjjvEyrohCp1ApTLXWRmgJ9zbnKcEATrs7U8kJ-uSwu44ZbH2GVG5s4GOq687RHvh88f1kYybX5dP07pa5RdLoaW2jchR0RMgWxgJ3D47Nv36ddFqpmI4UYEe_Ukmf_8-r868dzIagszMwXDSX7_zXMW55pjprcckMnD-FBjB_ZwSjwR3AH28dwbxVPyJ_AcomEkfaMgLrrrr_q2SkVRGSnPduIAmtG26-MclDGWQTF9OxoG17-FC5Ojn8cLdPYLSH10nCTNs4HBeMNeWTnkPKakGlKjWUjUDnkWRWipUq5XLnM5L4yiA3pYxUiV57z_Bks2q7FXWCNyL3nWBhRoywL6fJKisZnosFMOJkn8H7DN3s9FsWwIZkg_lrir438TeCQmDrRUCnr4UF389NGzbAhIvVeNxmGQFXKwlRSO0los0zVotIigTckEjveC50U0h6oTJc6fCVL4MNAQSoZJONdvFkQJkPFrWaUezPKoEp-PrwRu42q3Nu_Cy-Bt9MwvUnwtBa724Eml6UOoVACz8dVMk06GE26k6kSKGfrZ8aV-Uh79Wso9K1CMhkSyhf__62XcD9EcWa8ILkHi_XNLb4KkdK6eh3V4Q-yqRES
  priority: 102
  providerName: ProQuest
Title Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
URI https://www.ncbi.nlm.nih.gov/pubmed/31819566
https://www.proquest.com/docview/2327594189
https://search.proquest.com/docview/2323478521
https://pubmed.ncbi.nlm.nih.gov/PMC6875487
https://doaj.org/article/150cc8f0e9164459b48a4673606d2b82
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-tQ5r2MvFNxihGAvGUNnacxH7cykaH1DExJvXNsl0HKrF0Wrv_n7t8VI144yUP8UWJ7yP-nfO7C8BHabXX1svYZZmIpcpDrKTKYp0Fv-A8T0LNJpxd5dNb-W2ezfcg62phatK-d8tR9eduVC1_19zK-zs_7nhi4-vZJEeQjUB7PIABOuhOit5g3oL6WjUkd_oLz_jL7Ob76EYI6gRzCAfoxVQkl_dWorph_7-v5Z11qc-Z3FmELp7CUYse2WnzlM9gL1TP4WDWfh9_AdNpIIa0Z0TT3azWyzW7pHaI7HLNOkOEBaPNV0YZKOOspcSs2WSXXP4Sbi_Of06mcfuvhNhLzXVcWo_hxUtaj60NlNVgnilVKEoRcht44hArudymuU106p0OoaRodIhbecrTV7BfrarwBlgpUu95yLRYBImKtqmTovSJKEMirEwj-NTpzdw3LTEMphKkakOqNq2qIzgjpW5lqJF1fWL18Mu05jSIR71XZRIQpkqZaSeVlcQ1S_KFcEpE8J5MYpqq0G04mtM8UYXCuyQRfK4lKCDRMt62dQU4GWpt1ZM86UliIPn-cGd20wby2iDgLDItucLpfNgO05VETqvC6rGWSWWhEAhF8Lrxku2kO2eLoOj5T08r_RH0-rrNd-vlx_995Vs4RHinm8rJE9jfPDyGdwihNm4IAzXhQ3hydn51_WNYb0Tg8escz1Ew_QVJGx0H
link.rule.ids 230,315,730,783,787,867,888,2109,12237,21402,27938,27939,33280,33281,33758,33759,43593,43819,53806,53808,74350,74638
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BKwEXxGcbaKmRQJxCY8dx7BNqS6ssdBdEW6k3y3Gc0ktSmu3_x5N4w0aVuMYTJZ7xeGbs52eAD9woq4zlcZllLOZSuFhymcUqc7aiVCSuRxPOF6K44N8us8uw4NYFWOVqTuwn6qq1uEa-7yN_nilOpfpy8yfGW6NwdzVcofEQNpGqyo_qzcPjxc9f4yoLstlwxgbEO17Js_91fvbj8xljSAsziUU9Zf_9iXktMk1Rk2th6OQZPA35IzkYDP4cHrjmBTyahx3yl1AUDjHSliBQd9l21x2ZISEimXVkZQpXEVx-JViDEkoCKKYjR-vw8ldwcXJ8flTE4baE2HJFVVwb6x2M1hiRjXFY1_hKk0uX18wJ42hS-mypFCYVJlGpLZVzNfpj6TNXmtL0NWw0beO2gdQstZa6TLHK8TzjJi05q23Capcww9MIPq70pm8GUgztiwnUr0b96qDfCA5RqaMMUln3D9rbKx08Q_uM1FpZJ84nqpxnquTScESbJaJipWQR7KFJ9HAudHRIfSASmUv_lSSCT70EuqS3jDXhZIHvDJJbTSR3JpLeley0eWV2HVy50_8GXgTvx2Z8E-FpjWvvepmU59KnQhFsDaNk7LSfNPFMpoggn4yfiVamLc31757oW_hi0heUb_7_W3vwuDifn-rT2eL7W3jiMzo1HJbcgY3l7Z3b9VnTsnwXXOMv0T0UDA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgSBUXxDcphRoJxCls7NiOfUJly2oX2IJUKvVmOY4DvSRts_3_zCTesBES13iiJDN-nhnneYaQt8IZb5wXaSklT4VWIdVCy9TI4CvGVBZ6NuH6VC3PxZcLeRH5T12kVW7XxH6hrlqPe-Qz8PyFNIJpM6sjLeLHyeLj1XWKHaTwT2tsp3GX3AOvKLGNg56zcb8F69oIzgfuOzbnmZ2sz75_OOMcC8RMvFJfvP_fJXrHR035kzsOafGQPIiRJD0eTP-I3AnNY7K_jv_Kn5DlMiBb2lOk7G7a7rKjKyyNSFcd3RolVBQ3Yilmo5TRSI_p6HyXaP6UnC8-_5wv09g3IfXCMJPWzgPUWI2-2bmAGQ7knEKHouZBucCyEuKmUrlcuczkvjQh1IjMEmJYlrP8Gdlr2ia8ILTmufcsSMOrIAopXF4KXvuM1yHjTuQJebfVm70aymNYSCtQvxb1a6N-E_IJlTrKYFHr_kJ788tGjFiITb3XdRYgZBVCmlJoJ5B3lqmKl5on5AhNYocToiM07bHKdKHhKVlC3vcSCE6wjHfxjAF8DJa5mkgeTiQBVH46vDW7jaDu7N8pmJA34zDeiUS1JrS3vUwuCg1BUUKeD7Nk_GhYPvF0pkpIMZk_E61MR5rL333JbwVpJaSWB_9_rSOyD5iw31anX1-S-xDameHU5CHZ29zchlcQPm3K1z0u_gDJXRad
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+Steatosis+Index+Is+Associated+with+Type+1+Diabetes+Complications&rft.jtitle=Diabetes%2C+metabolic+syndrome+and+obesity&rft.au=Tripolino%2C+Cesare&rft.au=Irace%2C+Concetta&rft.au=Cutruzzola%2C+Antonio&rft.au=Parise%2C+Ma&rft.date=2019-11-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-7007&rft.eissn=1178-7007&rft.spage=2405&rft_id=info:doi/10.2147%2FDMSO.S221969&rft.externalDocID=A608789690
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7007&client=summon